Isoray. – Filings and Transcripts

NYSE American: CATX
Share price (11/9/26): $0.86
Market cap (11/9/26): $97.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Registration of securities for employees

Ownership Filter

Lantheus Holdings Inc.

Lantheus Holdings Inc., Lantheus Alpha Therapy, LLC

Lantheus Holdings Inc., Lantheus Alpha Therapy, LLC

Lantheus Alpha Therapy, LLC

Lantheus Holdings Inc.

News Filter

Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2026 Results

Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data From a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026

Perspective Therapeutics Presents Encouraging Incremental Data and Analyses From Phase 1/2a Trial of [212Pb]Bamzireotide Navoxetan (VMT-α-NET) in Advanced SSTR2 Expressing NETs

Perspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advanced SSTR2-Expressing NETs

Perspective Therapeutics Granted Fast Track Designation for [212Pb]PSV359 for the Treatment of Adult Patients With Locally Advanced Unresectable and/or Metastatic FAP-Positive Solitary Fibrous Tumors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Conflict Minerals disclosure

Notice of effectiveness

Conflict Minerals disclosure

Notice of effectiveness

Correspondence with the SEC